PI
BRLI

Placemark Investments’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Placemark Investments’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.09M Sell
33,852
-1,385
-4% -$40.1K 0.02% 837
2014
Q3 		$988K Sell
35,237
-5,053
-13% -$154K 0.02% 876
2014
Q2 		$1.22M Sell
40,290
-22,603
-36% -$624K 0.02% 783
2014
Q1 		$1.74M Buy
62,893
+3,385
+6% +$88.6K 0.03% 591
2013
Q4 		$1.52M Sell
59,508
-114
-0.2% -$3.51K 0.03% 670
2013
Q3 		$1.78M Sell
59,622
-1,354
-2% -$37.7K 0.03% 570
2013
Q2 		$1.75M Buy
+60,976
New +$1.68M 0.04% 544

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Placemark Investments's BRLI Position: Q4 2014 in Review

Placemark Investments reduced its BIO-REFERENCE LABS INC-NEW- (BRLI) stake by 3.9% in Q4 2014, selling an estimated $40.1K and leaving 33,852 shares worth $1.09M. The position accounts for 0.02% of the portfolio, ranked #837.

Placemark Investments first reported a position in BRLI in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.78M in Q3 2013. 182 funds tracked by Wall St. Rank hold BRLI as of Q4 2014.

  • Placemark Investments held 33,852 shares of BIO-REFERENCE LABS INC-NEW- worth $1.09M as of Q4 2014.
  • Placemark Investments sold 1,385 BIO-REFERENCE LABS INC-NEW- shares in Q4 2014, an estimated $40.1K.
  • BIO-REFERENCE LABS INC-NEW- made up 0.02% of Placemark Investments's portfolio in Q4 2014, its #837 holding.
  • Placemark Investments first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and has held it in 7 quarters since.
  • Placemark Investments's BIO-REFERENCE LABS INC-NEW- position peaked at $1.78M in Q3 2013.
  • 182 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.